Could a stomach bug treatment ease COPD symptoms?

NCT ID NCT07574879

Recruiting now Disease control Sponsor: Zagazig University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether treating a common stomach infection (H. pylori) can improve symptoms and lung function in people with COPD. Researchers will give standard antibiotic therapy to 54 H. pylori-positive COPD patients and then measure changes in their breathing tests and symptom scores. It is a small early-phase trial, so results will be preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Standard H. pylori eradication therapy (proton pump inhibitor and antibiotics)
What this could lead to: If successful, this could point toward a new way to improve COPD symptoms and lung function by treating an underlying infection.
What could go wrong: This is a very small, early-phase study with only 54 participants. It may not show clear benefits, and the results may not apply to all COPD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Helicobacter pylori infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) WITH POITIVE H PYLORI

Contacts and locations

Locations

Zagazig University outpatients clinics
RECRUITING

Zagazig, Elsharkia, 44, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.